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Post-proline cleaving peptidases are promising therapeutic targets for neurodegenerative diseases,
psychiatric conditions, metabolic disorders, and many cancers. Prolyl oligopeptidase (POP; E.C.
3.4.21.26) and ﬁbroblast activation protein a (FAP; E.C. 3.4.24.B28) are two post-proline cleaving
endopeptidases with very similar substrate speciﬁcities. Both enzymes are implicated in numerous
human diseases, but their study is impeded by the lack of speciﬁc substrate probes. We interrogated
a combinatorial library of proteolytic substrates and identiﬁed novel and selective substrates of POP
and FAP. These new sequences will be useful as probes for fundamental biochemical study, scaffolds
for inhibitor design, and triggers for controlled drug delivery.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
A major challenge in the development of pharmacologically via-
ble protease inhibitors is achieving sufﬁcient selectivity to avoid
undesirable off-target effects [1]. Highly speciﬁc substrates and
probes are also needed to enable fundamental studies of the roles
of proteases in health and disease. We have undertaken a biochem-
ical study of prolyl oligopeptidase and ﬁbroblast activation protein
a, two post-proline cleaving endopeptidases with very similar sub-
strate speciﬁcities that are proposed therapeutic targets for major
human diseases.
Prolyl oligopeptidase (POP; E.C. 3.4.21.26) is an 80 kDa soluble
endopeptidase that cleaves peptides less than 30 amino acids inchemical Societies. Published by E
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e).length C-terminal to proline residues, including many neuroactive
peptides [2]. POP is expressed in virtually all tissues, though partic-
ularly high levels are found in the brain and central nervous sys-
tem. POP has traditionally been regarded as a cytosolic enzyme,
but activity has also been reported in extracellular compartments,
including cerebrospinal ﬂuid, serum, and lung ﬂuid [2–4]. Levels of
POP activity are altered in many neurodegenerative conditions and
psychiatric disorders, leading to interest in POP as a therapeutic
target for these diseases. POP can be differentiated from FAP
in vitro via its selective inhibition by Z-prolylprolinal (ZPP) [5].
Although POP inhibitors are undergoing preclinical and clinical
evaluation, their development has been impeded because the roles
of POP in disease pathogenesis have not been fully elucidated [6].
Fibroblast activation proteina (FAP, also called seprase; E.C.
3.4.24.B28) is a type II integral membrane serine protease [7]. A
truncated soluble form of FAP, called antiplasmin-cleaving enzyme
(APCE), has also been reported [8]. FAP is closely related to dipep-
tidyl peptidase IV (DPPIV) and exhibits post-proline cleaving
dipeptidyl peptidase activity similar to DPPIV, but unlike DPPIV it
also exhibits endopeptidase activity toward gelatin and a2-anti-
plasmin [9]. FAP speciﬁcity is most commonly distinguished from
POP through its requirement for Gly at the P2 position [10]. Inlsevier B.V. All rights reserved.
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highly expressed on stromal ﬁbroblasts in virtually all epithelial
carcinomas and on tumor cells of some sarcomas [11]. FAP has
been implicated in tumorigenesis in animals, and FAP activity
has been associated with metastasis and poor prognosis in some
human cancers [12]. Collectively, these studies have aroused inter-
est in FAP as a target for cancer therapy, but validation efforts have
been hampered by the lack of highly selective inhibitors.
Recent studies have cast doubt on the traditional delineation
between the proteolytic activities of POP and FAP. Z-Gly-Pro-
AMC and other substrate-based probes that have been used to as-
say POP activity in cells, tissues, and body ﬂuids are now known to
be cleaved by FAP as well, potentially confounding the results of
those studies [2,8]. In addition, FAP (or APCE, its soluble form)
has been shown to contribute a portion of post-proline cleaving
endopeptidase activity in serum and other tissues [13]. POP activ-
ity affects cognitive function and may be altered in neurodegener-
ative diseases and psychiatric disorders, but studies conﬂict as to
whether POP activity is increased or decreased, and in most cases
the physiologic role of POP is unclear [6]. Furthermore, FAP has re-
cently been reported to cleave some neuroactive POP substrates
[14]. In addition, both FAP and POP play roles in inﬂammation
and immunomodulation, though they are incompletely understood
[4,15]. Thus, there is a clear need to clarify the substrate speciﬁci-
ties of these two enzymes to facilitate the design of selective inhib-
itors and to enable fundamental biochemical studies of their roles
in disease processes. To address this need, we employed a combi-
natorial library of internally quenched ﬂuorogenic probes to com-
paratively proﬁle the substrate speciﬁcities of POP and FAP.
2. Materials and methods
2.1. Materials
Human recombinant POP, human recombinant FAP, and POP
inhibitor ZPP were obtained from R&D Systems (Minneapolis,
MN). Cleavage of the generic probe Z-Gly-Pro-AMC by both en-
zymes was consistent and reproducible across enzyme lots
(Fig. S1 and S2). POP and FAP were supplied at 0.5 mg/mL, diluted
to 50 lg/mL in their respective storage buffers (as recommended
by the manufacturer), and stored at 80 C until use. All other re-
agents and materials were obtained from Sigma–Aldrich (St. Louis,
MO) or VWR (Radnor, PA).
2.2. Substrate speciﬁcity proﬁling
Analysis of POP and FAP substrate speciﬁcities was performed
using a library of 3375 internally quenched ﬂuorogenic probes
(IQFPs) (Mimotopes, Clayton, Victoria, Australia). These probes re-
main optically silent in the uncleaved state, but upon cleavage they
emit a ﬂuorescent signal with intensity proportional to the extent
of cleavage. Peptides in this library contain the sequence MCA-Gly-
Gly-Gly-Xaa-Yaa-Zaa-Gly-Gly-DPA-Lys-Lys, in which Xaa, Yaa, and
Zaa correspond to variable residues comprising equimolar mix-
tures of Ala/Val, Asp/Glu, Phe/Tyr, Ile/Leu, Lys/Arg, Asn/Gln, Ser/
Thr, or Pro (Fig. 1A). Thus, each well of the library contains an equi-
molar mixture of up to eight individual peptides. This library has
been validated previously through substrate speciﬁcity proﬁling
of recombinant proteases from each of the major protease classes
[16].
IQFP library screens were performed as described [3] with the
following modiﬁcations. Before starting the assay, aliquots of
frozen POP and FAP were thawed on ice and diluted to 10 lg/mL
in the assay buffers recommended by the manufacturer (POP –
25 mM Tris, 250 mM NaCl, 2.5 mM DTT, pH 7.5; FAP – 50 mM Tris,1 M NaCl, 1 mg/mL BSA, pH 7.5). The reaction was initiated at
t = 0 min by the addition of IQFP. In each well, the ﬁnal IQFP con-
centration was 62.5 lM and the ﬁnal enzyme concentration was
1 lg/mL. Endpoint ﬂuorescence intensity fold change after 6 h at
room temperature was calculated as Fﬁnal/Finitial. No ﬂuorescence
enhancement was observed in wells lacking enzyme (data not
shown). Library wells were considered to be cleaved if an endpoint
ﬂuorescence intensity fold change value greater than 2 was
observed.
2.3. Deconvolution and inhibition assays
The individual sequences derived from each selected IQFP motif
were assayed individually as described [3]with the following mod-
iﬁcations. IQFPs were custom synthesized, conﬁrmed by mass
spectrometry, and provided as lyophilized powders (Mimotopes).
IQFP stock solutions were prepared in dimethylsulfoxide (DMSO)
and diluted to 1 mM in assay buffer (assay buffers as described
above). Enzyme stock solutions were diluted to 10 lg/mL in assay
buffer immediately before use. In each assay well, the ﬁnal IQFP
concentration was 25 lM and the ﬁnal enzyme concentration
was1 lg/mL.
Where indicated, substrate cleavage sites were conﬁrmed by
identiﬁcation of N-terminal and C-terminal substrate fragments
by matrix-assisted laser desorption/ionization time-of-ﬂight (MAL-
DI-TOF) mass spectrometry using an ABI 4800 MALDI-TOF/TOF
mass spectrometer (Applied Biosystems, Carlsbad, CA) as described
[3]. To determine the effect of POP inhibitor ZPP on cleavage of se-
lected IQFPs, experiments were conducted as described except en-
zyme solutions (1 lg/mL) were incubated with 5 lM ZPP for
30 min at room temperature prior to the start of the experiment.
Experiments using physiologically derived substrates were per-
formed as describe above. Sequences were synthesized as indi-
cated in Table 1, with MCA-Gly-Gly appended to the N-terminus
and Gly-Gly-DPA-Lys-Lys appended to the C-terminus.
2.4. Statistical analysis
Statistical signiﬁcance was assessed by analysis of variance and
two-tailed Student’s t-test. Equality of variance was determined by
F-test. Differences were considered signiﬁcant if they exhibited p
values <0.05 in Student’s t-test. Data analyses were performed
using Microsoft Excel and Analyst Soft Stat Plus. All measurements
were obtained in duplicate. All data presented are representative of
at least two independent experiments performed with separate en-
zyme preparations.
3. Results and discussion
3.1. Substrate speciﬁcity proﬁling
Highly speciﬁc substrate probes are needed to enable biochem-
ical studies of prolyl oligopeptidase and ﬁbroblast activation pro-
tein a and to facilitate discovery of selective inhibitors for these
potential therapeutic targets. We have performed the ﬁrst unbi-
ased direct comparison of the proteolytic activities of POP and
FAP, which provided new information about the substrate speciﬁc-
ities of both enzymes and identiﬁed selective probes (Fig. 1). While
40 IQFP motifs were cleaved by both enzymes (Table S1), a consid-
erable number of wells were cleaved by only one (17 for POP and
15 for FAP) (Table 1). Both enzymes exclusively cleaved substrates
containing Pro.
An analysis of the amino acid distribution of POP substrates
revealed that Pro is strongly preferred, although not absolutely
required, at the Xaa position (74% of all POP substrates; Fig. 1E).
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Fig. 1. Substrate speciﬁcities of POP and FAP. (A) Schematic illustration of a representative internally quenched ﬂuorogenic probe. (B–C) Graphical heatmap representations
of the substrate speciﬁcities of POP (B) and FAP (C). Colored squares represent individual wells of stacked 96 well microplates [3]. The numbers at the bottom of the heat map
corresponds to the ﬂuorescence fold change values (upper and lower limit) used in generating the heat maps. The fold change values were calculated as described in Section 2.
(D) Venn diagram indicating the numbers of selective and promiscuous IQFP motifs detected. (E–F) Amino acid distribution of all IQFP sequences cleaved by POP (E) and FAP
(F). Individual motifs are listed in Tables 1 and S1. (G) Amino acid distribution of IQFP sequences cleaved by POP aligned with Pro ﬁxed at P1. The % amino acid distribution
values for each pie chart are presented in Tables S3 and S4.
Table 1
Substrate sequences cleaved selectively by POP or by FAP.a
Cleaved only by POP Cleaved only by FAP
Xaa Yaa Zaa Fold change Xaa Yaa Zaa Fold change
P D/E I/L 2.41 P A/V D/E 3.45
P P F/Y 2.30 P A/V K/R 10.61
F/Y P I/L 2.13 P D/E A/V 4.42
I/L P I/L 2.67 P D/E K/R 4.72
K/R P I/L 2.30 P D/E N/Q 2.38
K/R P F/Y 2.33 P F/Y F/Y 11.45
K/R P S/T 2.04 P I/L D/E 4.44
S/T P S/T 2.34 P I/L F/Y 5.38
A/V K/R P 2.11 P I/L K/R 9.21
F/Y A/V P 4.19 P K/R D/E 6.46
F/Y K/R P 2.31 P K/R F/Y 8.17
F/Y S/T P 2.39 P K/R K/R 10.62
I/L N/Q P 2.39 P K/R N/Q 16.64
I/L S/T P 3.55 P N/Q F/Y 9.59
K/R A/V P 2.10
S/T F/Y P 2.03
a Selective IQFP motifs were identiﬁed by screening a combinatorial substrate
library. For each sequence, the endpoint ﬂuorescence fold change value is shown.
IQFP wells were considered to be cleaved if fold change values greater than 2 were
observed.
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in Xaa at least once. A substantial fraction of POP substrates con-
tained Pro at the Yaa and Zaa positions as well (12% and 28%,
respectively). POP was also found to cleave one motif in which
Pro was found at both the Xaa and Yaa positions (Pro-Pro-Phe/
Tyr), albeit weakly. In all substrates cleaved by POP, charged resi-
dues were strongly disfavored at the position following Pro; Arg/
Lys represented 11% of Yaa and 5% of Zaa, while Asp/Glu repre-
sented 7% of Yaa and 5% of Zaa. When POP substrates were aligned
with Pro ﬁxed at the P1 position, the bias against charged residues
mapped to the P10 and P20 positions (Fig. 1G). In contrast, cationic
residues were prominent in the P2 position, consistent with a
study of POP from porcine kidney in which cationic residues were
preferred over anionic residues at P2 [17].
Surprisingly few studies of POP substrate speciﬁcity based on
positional scanning libraries have been published. Gorrao et al.
interrogated POP cleavage of a positional scanning library based
on bradykinin and observed a preference for Arg/Asn/Ile/Leu at
the P2 and P3 positions, while P10 and P20 were promiscuous
[18]. A comparative study of three bacterial POPs revealed a pref-
erence for Gln or Tyr at P10 [19]. Another bacterial POP exhibited
Xaa Yaa Zaa
Xaa Yaa Zaa
Sequences cleaved only by POP: 
Sequences cleaved only by FAP: 
A
B
Fig. 2. Amino acid distribution of selective probe sequences. In POP-speciﬁc
sequences (A), Pro was found at all three variable positions and charged residues
were disfavored at P10 and P20 . In FAP-speciﬁc sequences (B), Pro was found
exclusively at Xaa and charged residues were heavily favored at P10 and P20 . The %
amino acid distribution values for each pie chart are presented in Table S5.
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although Asp/Lys were the least favored residues at this position,
consistent with our ﬁndings. However, extensibility of these obser-
vations from bacterial to human POP is unknown.
In contrast to POP, FAP exhibited an absolute requirement for
Pro in the Xaa position, consistent with the well-known Gly-Pro
FAP cleavage site [10,21,22]. Also unlike POP, FAP did not exhibit
a clear preference for any residue at P10 or P20. Among FAP sub-
strates, no residue represented less than 13% and 11% of P10 and
P20, respectively (Fig. 1F). The lone exception was Pro, which was
not found at P10 in any FAP substrates. These data deviate some-
what from previous studies. Positional scanning probe libraries
based on the a2-antiplasmin cleavage site indicated preferences
for Ala/Tyr/Ser/Asn at P10 and Phe/Tyr at P20 [10,22]. Mass spec-
trometry-based analysis of collagen I-derived gelatin digested by
FAP also suggested a preference for Ala at P10 [21]. These differ-
ences may be highly dependent on the context of the overall pep-
tide sequence; while previous positional scanning libraries were
designed from physiological substrates [10,22], our study is the
ﬁrst to interrogate an unbiased combinatorial substrate library.POP only FAP only
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Fig. 3. Deconvolution of IQFP substrates. Extent of cleavage is expressed as endpoint ﬂ
denote cleavage by POP. Error bars represent standard deviations. ⁄p < 0.05 versus FVP aWe also analyzed the substrate sequences cleaved exclusively
by only one of the two enzymes, revealing several key observations
(Fig. 2 and Table 1). First, FAP-speciﬁc IQFPs contain Pro exclusively
at the Xaa position, whereas all but one of the POP-speciﬁc sub-
strates contained Pro at either Yaa or Zaa. Second, charged residues
(Arg/Lys and Asp/Glu) are disfavored at P10 and P20 in POP-speciﬁc
substrates, but are preferred in the same positions in FAP-speciﬁc
substrates (54% and 47% of P10 and P20, respectively). Third, Ser/
Thr residues are completely absent from FAP-speciﬁc sequences.
These observations could serve as the basis for future design of
highly selective probes and inhibitors. These guidelines can also
be used in the design of FAP-activated prodrugs, which have been
recently sought as a means of targeting the microenvironment of
epithelial tumors but are vulnerable to undesired cleavage by
POP [23].
3.2. Deconvolution of selected IQFP motifs
To further characterize the substrate speciﬁcities of POP and
FAP, constituent sequences comprising two POP-speciﬁc motifs,
two FAP-speciﬁc motifs, and four dual-speciﬁcity motifs were indi-
vidually synthesized and conﬁrmed by mass spectrometry. Fine
amino acid substrate speciﬁcities of these motifs were determined
by quantifying endpoint ﬂuorescence fold change following incu-
bation of either POP or FAP with each individual substrate
(Fig. 3). Exclusivity of both POP-speciﬁc motifs was conﬁrmed
upon deconvolution. Among the constituent sequences of the motif
Phe/Tyr-Ala/Val-Pro, the substrate Phe-Ala-Pro was strongly pre-
ferred. In contrast, the four sequences comprising the motif Ile/
Leu-Ser/Thr-Pro were all cleaved to a similar extent. Among the
constituent sequences of the two motifs believed to be FAP-speciﬁc
(Pro-Arg/Lys-Asn/Gln and Pro-Phe/Tyr-Phe/Tyr), FAP did not exhi-
bit any clear preferences. Upon deconvolution, one of these two
motifs (Pro-Phe/Tyr-Phe/Tyr) was also cleaved by POP, underscor-
ing the need for secondary conﬁrmation of substrate motifs de-
rived from combinatorial library screens.
Of the dual-speciﬁcity motifs that were selected for deconvolu-
tion, all individual sequences were cleaved by both enzymes. Nota-
ble substrate speciﬁcity preferences among these sequences
include Pro-Phe-Thr, which was strongly cleaved by POP, and
Pro-Tyr-Asp, which was strongly cleaved by FAP. One noteworthy
observation was the inability to exchange Asp/Glu and Phe/Tyr at
the P10 and P20 positions; Pro-Phe/Tyr-Asp/Glu sequences were
extensively cleaved by both POP and FAP, but neither enzymePOP and FAP Control 
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uorescence fold change at 6 h. Dark bars denote cleavage by FAP, while light bars
nd YAP for cleavage by POP. ⁄⁄p < 0.05 versus PFS, PYS, and PYT for cleavage by POP.
K. Jambunathan et al. / FEBS Letters 586 (2012) 2507–2512 2511exhibited substantial cleavage of Pro-Asp/Glu-Phe-Tyr. In addition,
POP exhibited only modest cleavage of the motifs Pro-Ser/Thr-Asn/
Gln and Pro-Asn/Gln-Ser/Thr. Post-proline cleavage of deconvo-
luted substrates was also conﬁrmed by MALDI mass spectrometry
(Table S2). A subset of these sequences was used to assay the
inhibitory effects of ZPP against both FAP and POP (Fig. S3). As ex-
pected, cleavage of all substrates by POP was completely inhibited
by 5 lM ZPP (>93% inhibition for all substrates tested), whereas
FAP activity was unaffected.
3.3. Cleavage of physiologically derived substrates
We sought to determine if the overlap in POP and FAP substrate
speciﬁcities we detected in this 3-mer IQFP library may also extend
to physiologic substrates. Although FAP has recently been reported
to exhibit dipeptidyl peptidase activity toward several neuropep-
tides, including POP substrates [14], there has been little investiga-
tion of the potential overlap between the activities of these two
enzymes. This is particularly important in elucidating the physio-
logic roles of POP, which is widely expressed and exhibits less
stringent substrate speciﬁcity than FAP. Thus, we designed and
synthesized IQFPs based on two POP substrates (bradykinin and
substance P) and two FAP substrates (gelatin and a-antiplasmin)
that contained the same ﬂuorophore-quencher probe architecture
as the peptides in our IQFP library (Table 2) [10,18,21,24].
We conﬁrmed that all substrates were cleaved by their cognate
enzymes as expected (Fig. 4). However, we also detectedTable 2
Summary of physiologically relevant peptides.a
Peptide Source Proteaseb R
GFSPFRQED Bradykinin POP [1
RPKPQQFFGLM Substance P POP [2
GASGPAGPA Gelatin FAP [2
GEPGPPGPA Gelatin FAP [2
GTSGPNQEQE a-Antiplasmin FAP [1
GTAGPNQEQE a-Antiplasmin FAP [1
a Physiologically derived substrates were adapted from the indicated literature referen
a cleavage site.
b The canonical protease according to literature is indicated.
c As determined by MALDI mass spectrometry.
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Fig. 4. Cleavage of physiologically derived peptides. Sequences are summarized in Tab
derived substrate. Extent of cleavage is expressed as endpoint ﬂuorescence fold change
Error bars represent standard deviations. ⁄p < 0.05 and ⁄⁄p < 0.01 versus cleavage of theconsiderable promiscuous cleavage. A POP substrate derived from
substance P was cleaved by FAP, and all four FAP substrates (de-
rived from gelatin and a-antiplasmin) were cleaved by POP. MALDI
mass spectrometry analysis conﬁrmed post-proline cleavage sites
(Table 2). Strikingly, the substance P-derived sequence Arg-Pro-
Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met, which does not contain
Gly-Pro, was reproducibly cleaved by FAP. This may suggest that
the requirement for a Gly-Pro motif is not ironclad, as a recent
mass spectrometry-based study also reported [21]. Although these
substrates are modiﬁed from their native forms by truncation and
by the addition of ﬂuorophore and quencher moieties, our observa-
tions warrant further investigation to determine whether promis-
cuous cleavage of native substrates occurs under physiologically
relevant conditions.
3.4. Limitations
Several caveats should be noted when interpreting our data.
First, the IQFP library we employed contains only three variable
positions and is by design restricted to endopeptidase substrates.
Also, the library lacks some residues that have been found in POP
and FAP substrates, such as His and Trp, which interfere with ﬂuo-
rescence or may pose synthetic challenges in the IQFP library for-
mat. Finally, because library wells contain a mixture of IQFPs, an
additional secondary deconvolution step is required to determine
ﬁne substrate speciﬁcity and to assess enzyme kinetics. However,
these limitations are offset by the beneﬁts of a concise yeteference POP cleavage site(s)c FAP cleavage site(s) c
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le 2. Promiscuous cleavage was observed for all substrates except the bradykinin-
at 6 h. Dark bars denote cleavage by FAP, while light bars denote cleavage by POP.
same substrate by the non-canonical enzyme.
2512 K. Jambunathan et al. / FEBS Letters 586 (2012) 2507–2512unbiased library that can be screened in only six microplates. An-
other important consideration is common to all IQFP substrates –
synthetic ﬂuorophore-modiﬁed peptides may not recapitulate the
folded structures of true endogenous substrates. Thus, mass spec-
trometry-based and computational studies [25] may be required to
extend biochemical observations from synthetic substrates to
physiologic ones. Nonetheless, libraries such as the one employed
here can be used as a ﬁrst step in the identiﬁcation of selective
probes and inhibitors to distinguish closely related enzymes.
4. Conclusion
In summary, we comparatively proﬁled the substrate speciﬁci-
ties of POP and FAP and identiﬁed novel and selective substrates
that will be useful as scaffolds for inhibitor design, probes for fun-
damental biochemical study, and triggers for controlled drug
delivery.
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